Lumateperone
CAS 313368-91-1Small Molecule
Overview
Lumateperone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3306803).
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Lumateperone expires 10 Dec 2040 and exclusivity 24 Apr 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one
- Canonical SMILES
- CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F
- InChIKey
- HOIIHACBCFLJET-SFTDATJTSA-N
Verified Supplier Partner
Do you supply Lumateperone? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.